MICRO THERAPEUTICS, INC. DBA EV3 AXIUM PRIME BRPL 3D; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
|
Back to Search Results |
|
Model Number APB-2-4-3D-ES |
Device Problem
Separation Failure (2547)
|
Patient Problem
Device Embedded In Tissue or Plaque (3165)
|
Event Date 06/30/2022 |
Event Type
Injury
|
Event Description
|
Medtronic received a report that the axium prime coil could not be detached and the pushwire separated.The patient was undergoing treatment for an unruptured, saccular aneurysm located in the ba-top.The max diameter was 5mm, and the neck diameter was 3mm.The patient's blood flow was normal, and their vessel tortuosity was moderate.It was reported that when the coil reached the detached zone an attempt was made to detach it using the instant detacher (id), but it did not detach.Three detachment attempts were made with the id, and one manual detachment attempt was made.Another id was not used.A breakage occurred when the delivery wire was about to be pulled, but it was pulled out as is.As it was broken, a few centimeters of delivery wire remained inside the patient's body, but it was said there was no effect on the patient. the patient did not experience any health damage.The devices were prepared according to the instructions for use (ifu).Ancillary devices include a 7fr medikit super sheath, fubuki 7fr guide catheter, headway 17 microcatheter, and a chikai 14 guidewire.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received reported there were no issues during the procedure prior to non-detachments.The cause was undetermined.
|
|
Manufacturer Narrative
|
B5.Updated with additional information received.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|